Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07118683
Recruiting Observational

BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS

NCT07118683 · tracked via the Priya Life Science Brazil tracker
Sponsor
Hospital Alemão Oswaldo Cruz
Phase
Observational
Started
2025-08-15
Last updated
2026-05-22

Condition(s) studied

AIDS (Acquired Immunodeficiency Syndrome)Cardiovascular and Cerebrovascular DiseasesRespiratory ComorbiditiesChronic Kidney DiseaseCancer

Study summary

BRAVO proposes the establishment of a comprehensive registry of chronic noncommunicable diseases (NCDs), providing crucial data for the formulation of effective health policies for people living with HIV/AIDS (PLWHA). BRAVO is a cross-sectional study, that will collect on the study allocation sociodemographic data, risk factors related to the main NCDs, physical examination data and samples for determination of biochemical and metabolic parameters. To this end, the study will include co-participating research centers from the 5 Brazilian geographic macro-regions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 or over; * Confirmed HIV or AIDS diagnosis; * Signature of consent form. Exclusion Criteria: * Indigenous population or those in prison in open or closed regimes; * Patients hospitalized at the time of signing the Consent Form.

Primary outcome measure(s)

Trial sites (9)

FacilityCityRegionStatus
Hospital das Clínicas da Universidade Federal de Goiás Goiânia Goiás Recruiting
Faculdade de Medicina da Universidade Federal de Minas Gerais Belo Horizonte Minas Gerais Active Not Recruiting
Hospital de Clínicas da Universidade Federal do Paraná Curitiba Paraná Recruiting
Hospital Federal dos Servidores do Estado do Rio de Janeiro Rio de Janeiro Rio de Janeiro Recruiting
Hospital Federal de Santa Maria Santa Maria Rio Grande do Sul Recruiting
Centro de Pesquisa Clínica Dom Bosco Araçatuba São Paulo Recruiting
Faculdade de Medicina de Botucatu da UNESP Botucatu São Paulo Not Yet Recruiting
Centro Universitário FMABC Santo André São Paulo Recruiting
Instituto de Infectologia Emílio Ribas São Paulo São Paulo Recruiting

More Hospital Alemão Oswaldo Cruz trials in Brazil

Implementation of the START Intervention in Brazil: a Controlled Feasibility Trial Recruiting
Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait Recruiting
Antimicrobial Stewardship Program Implementation in Brazilian Public Hospitals (PeGASUS) Active, not recruiting

Other trials for the same condition

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases Recruiting
Exercise Training in Women With Metastatic Breast Cancer Starting soon
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria Active, not recruiting
Pan Tumor Rollover Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07118683 on ClinicalTrials.gov ↗ ← All trials in Brazil